Ask HopeStage to review this study with me
Study ID: NCT04218981. We help you review the study, but cannot decide medical eligibility.
CompletedNCT04218981
Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
This study is completed. It focuses on mental health and currently lists study information in China.
Mental health, Common Mental DisorderOtherFrom 18 Years to 50 Years
Key information made simple
What is this study testing?
This study is testing whether a blood test or biomarker may be useful for adults experiencing mental health.
What would participation involve?
Participants may complete a blood test or biomarker, complete questionnaires or follow-up assessments, complete imaging scans. The registry lists locations in China.
Who is it mainly for?
This study appears to be mainly for adults with mental health.
What should you check before joining?
Ask about whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
HopeStage note
This page is based on public study information. It does not mean the study is right for you. Check the official record and speak with the study team or a clinician before deciding.
Your next step
The official record suggests in-person participation through a hospital, with sites including The Second Xiangya Hospital of Central South University in Changsha. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually matching the main diagnosis, while common reasons not to take part include pregnancy or breastfeeding. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateStarted: January 15, 2020
- Recruitment status
- Completed
- Estimated enrollment
- Not clearly listed
- Sponsor
- Central South University
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other / unclear
- Study phase
- Not clearly listed
- Locations
- China
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT04218981
- Official title
- Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders
- Official source
- Official registry link
Want help reviewing this study?
Study ID: NCT04218981. We help you review the study, but cannot decide medical eligibility.
For you
Taking part may help clarify how this condition is measured or understood.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in China.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring blood test or biological sample for people with mental health. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Why is the study type not clearly categorized?
The study type is not clearly categorized in the public registry. Focus on the objective, required tasks, visits, any intervention, and eligibility criteria, then ask the study team to confirm.
Who might this study be for?
This study may concern people with mental health; age range: From 18 Years to 50 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
The public registry does not clearly describe all participation steps. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What risks or points should I check?
The public registry does not make the main risk category clear. Ask the study team what activities are required, what could feel uncomfortable, how safety is monitored, and what happens if you want to stop. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Central South University, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The registry indicates that this study is completed. It may still be useful for understanding the research, but you are unlikely to be able to join.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me